Camden, NJ ― Anjalee Khemlani reports in NJBIZ that Cooper University Health Care received a $2 million grant, the largest since 2013, to support the expansion of the cancer genetics program at MD Anderson Cancer Center at Cooper.
The grant comes from the William G. Rohrer Charitable Foundation, which was funded by the estate of William G. Rohrer, a former banker, businessman, public official and humanitarian from Camden County whose life was dedicated to improving the educational and economic prosperity of southern New Jersey, according to a statement from Cooper.
“With this grant, we are taking a major step forward toward our goal of conquering cancer,” said George E. Norcross III, chairman of the Cooper board. “I am deeply appreciative of the William G. Rohrer Charitable Foundation’s support for MD Anderson Cooper and for sharing our commitment to bringing the best possible cancer care to patients across the region.”
The grant comes from the William G. Rohrer Charitable Foundation, which was funded by the estate of William G. Rohrer, a former banker, businessman, public official and humanitarian from Camden County whose life was dedicated to improving the educational and economic prosperity of southern New Jersey, according to a statement from Cooper.
“With this grant, we are taking a major step forward toward our goal of conquering cancer,” said George E. Norcross III, chairman of the Cooper board. “I am deeply appreciative of the William G. Rohrer Charitable Foundation’s support for MD Anderson Cooper and for sharing our commitment to bringing the best possible cancer care to patients across the region.”
The cancer genetics program helps provide counseling, testing and long-term cancer risk reduction strategies for those with increased risk of cancer from hereditary mutations.
Generosa Grana, director of the MD Anderson Cancer Center at Cooper, said the funding helps advance the treatment of a variety of cancers.
“Cancer is a genetically driven disease,” Grana said. “Genetic variation in healthy individuals may predispose them to developing certain cancers, and genetic alterations in the cancer cells themselves determine prognosis and response to anti-cancer drugs. Until recently, certain types of cancer, such as breast and lung, were largely treated the same irrespective of their genetic makeup.”
Linda Rohrer, president of the foundation, was born at Cooper and served on the Cooper Board of Trustees.
“This grant is a reflection of my family’s longstanding love of Cooper and our great admiration for the life-saving care and research that takes place here each and every day,” she said. “The cancer genetics program at MD Anderson Cooper represents the future of cancer care, and my dad would want to be a part of it.”
Generosa Grana, director of the MD Anderson Cancer Center at Cooper, said the funding helps advance the treatment of a variety of cancers.
“Cancer is a genetically driven disease,” Grana said. “Genetic variation in healthy individuals may predispose them to developing certain cancers, and genetic alterations in the cancer cells themselves determine prognosis and response to anti-cancer drugs. Until recently, certain types of cancer, such as breast and lung, were largely treated the same irrespective of their genetic makeup.”
Linda Rohrer, president of the foundation, was born at Cooper and served on the Cooper Board of Trustees.
“This grant is a reflection of my family’s longstanding love of Cooper and our great admiration for the life-saving care and research that takes place here each and every day,” she said. “The cancer genetics program at MD Anderson Cooper represents the future of cancer care, and my dad would want to be a part of it.”
